<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37097178</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2379-5042</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>22</Day></PubDate></JournalIssue><Title>mSphere</Title><ISOAbbreviation>mSphere</ISOAbbreviation></Journal><ArticleTitle>Persistent Coxsackievirus B3 Infection in Pancreatic Ductal Cells <i>In Vitro</i> Downregulates Cellular Polyamine Metabolism.</ArticleTitle><Pagination><StartPage>e0003623</StartPage><MedlinePgn>e0003623</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00036-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/msphere.00036-23</ELocationID><Abstract><AbstractText>Picornaviruses infect a wide variety of cell types <i>in vitro</i>, with rapid replication kinetics and pronounced cytopathic effect. Coxsackievirus B3 (CVB3) can also establish a persistent infection <i>in vivo</i> that can lead to pathology, including dilated cardiomyopathy and myocarditis. One model system to study persistent infection is the pancreatic ductal cell line PANC-1, which CVB3 infects and is maintained indefinitely. We have characterized this model for CVB3 infection to study persistent infection for over 6 months. We find that CVB3 rapidly replicates within PANC-1 cells without robust cytopathic effect, and after 1 month in culture, titers stabilize. We find that infection does not significantly affect cellular viability. Persistent virus reverts to lytic infection when transferred to Huh7 or Vero cells. We find that persistent CVB3 adapts to PANC-1 cells via mutation of its capsid proteins and, curiously, the viral polymerase (3Dpol) to generate a high-fidelity polymerase. Persistent infection is associated with reduced cleavage of eIF4G, reduced plaque size, and decreasing particle infectivity. We further find that polyamine metabolism is altered in persistently infected cells, with the rate-limiting enzyme ornithine decarboxylase (ODC1) reduced in translation. We further find that targeting polyamine synthesis reduces persistent infection without affecting the viability of the PANC-1 cells. Finally, we find that viral fidelity is essential to maintaining CVB3 infection, and targeting viral fidelity reduces persistent virus infection. Together, these data highlight a novel role for polyamines and fidelity in persistent CVB3 infection and suggest avenues for therapeutic development to target persistent infection. <b>IMPORTANCE</b> Enteroviruses are significant human pathogens that can cause severe disease, including cardiomyopathies. Viruses like coxsackievirus B3 (CVB3) can cause tissue damage by lytically infecting cells; however, CVB3 can also persistently infect, which has been associated with several pathologies. Studying persistent infection <i>in vitro</i> is challenging, as CVB3 lytically infects most cellular model systems. Here, we show that CVB3 establishes persistent infection in pancreatic ductal cells <i>in vitro</i>, similar to prior studies on other coxsackieviruses. We also show that this infection results in adaptation of the virus to these cells, as well as changes to cellular metabolism of polyamines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mastrodomenico</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LoMascolo</LastName><ForeName>Natalie J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firpo</LastName><ForeName>Mason R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanueva Guzman</LastName><ForeName>Maria Del Mar</ForeName><Initials>MDM</Initials><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaporowski</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounce</LastName><ForeName>Bryan C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0003-1710-5362</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007508</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM138199</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>mSphere</MedlineTA><NlmUniqueID>101674533</NlmUniqueID><ISSNLinking>2379-5042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011073">Polyamines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000088562" MajorTopicYN="N">Persistent Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011073" MajorTopicYN="N">Polyamines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">pancreatic ductal cells</Keyword><Keyword MajorTopicYN="N">persistence</Keyword><Keyword MajorTopicYN="N">polyamines</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>17</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37097178</ArticleId><ArticleId IdType="pmc">PMC10286709</ArticleId><ArticleId IdType="doi">10.1128/msphere.00036-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chapman NM, Kim KS. 2008. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 323:275–292. doi:10.1007/978-3-540-75546-3_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-75546-3_13</ArticleId><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Alidjinou EK, Hober D. 2022. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol 18:503–516. doi:10.1038/s41574-022-00688-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd RE, Tamhankar M, Lernmark Å. 2022. Enteroviruses and type 1 diabetes: multiple mechanisms and factors? Annu Rev Med 73:483–499. doi:10.1146/annurev-med-042320-015952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042320-015952</ArticleId><ArticleId IdType="pmc">PMC9242008</ArticleId><ArticleId IdType="pubmed">34794324</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuer R, Ruller CM, An N, Tabor-Godwin JM, Rhoades RE, Maciejewski S, Pagarigan RR, Cornell CT, Crocker SJ, Kiosses WB, Pham-Mitchell N, Campbell IL, Whitton JL. 2009. Viral persistence and chronic immunopathology in the adult central nervous system following coxsackievirus infection during the neonatal period. J Virol 83:9356–9369. doi:10.1128/JVI.02382-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02382-07</ArticleId><ArticleId IdType="pmc">PMC2738251</ArticleId><ArticleId IdType="pubmed">19570873</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam PE, Messner RP. 1999. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J Virol 73:10113–10121. doi:10.1128/JVI.73.12.10113-10121.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.12.10113-10121.1999</ArticleId><ArticleId IdType="pmc">PMC113063</ArticleId><ArticleId IdType="pubmed">10559326</ArticleId></ArticleIdList></Reference><Reference><Citation>Sane F, Caloone D, Gmyr V, Engelmann I, Belaich S, Kerr-Conte J, Pattou F, Desailloud R, Hober D. 2013. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol Life Sci 70:4169–4180. doi:10.1007/s00018-013-1383-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1383-4</ArticleId><ArticleId IdType="pmc">PMC11113870</ArticleId><ArticleId IdType="pubmed">23775130</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkimaa A, Kimura B, Sioofy-Khojine A-B, Lin J, Laiho J, Oikarinen S, Hyöty H. 2020. Genetic adaptation of coxsackievirus B1 during persistent infection in pancreatic cells. Microorganisms 8:1790. doi:10.3390/microorganisms8111790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111790</ArticleId><ArticleId IdType="pmc">PMC7697981</ArticleId><ArticleId IdType="pubmed">33203081</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann I, Alidjinou EK, Bertin A, Bossu J, Villenet C, Figeac M, Sane F, Hober D. 2017. Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells. Cell Mol Life Sci 74:3851–3861. doi:10.1007/s00018-017-2567-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2567-0</ArticleId><ArticleId IdType="pmc">PMC11107484</ArticleId><ArticleId IdType="pubmed">28601984</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchacher T, Honkimaa A, Välikangas T, Lietzén N, Hirvonen MK, Laiho JE, Sioofy-Khojine A-B, Eskelinen E-L, Hyöty H, Elo LL, Lahesmaa R. 2022. Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells. iScience 25:103653. doi:10.1016/j.isci.2021.103653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103653</ArticleId><ArticleId IdType="pmc">PMC8728469</ArticleId><ArticleId IdType="pubmed">35024587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lietzén N, Hirvonen K, Honkimaa A, Buchacher T, Laiho JE, Oikarinen S, Mazur MA, Flodström-Tullberg M, Dufour E, Sioofy-Khojine A-B, Hyöty H, Lahesmaa R. 2019. Coxsackievirus B persistence modifies the proteome and the secretome of pancreatic ductal cells. iScience 19:340–357. doi:10.1016/j.isci.2019.07.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2019.07.040</ArticleId><ArticleId IdType="pmc">PMC6699423</ArticleId><ArticleId IdType="pubmed">31404834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulinski JM, Leonardo SM, Mounce BC, Malherbe L, Gauld SB, Tarakanova VL. 2012. Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection. J Virol 86:12826–12837. doi:10.1128/JVI.00917-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00917-12</ArticleId><ArticleId IdType="pmc">PMC3497635</ArticleId><ArticleId IdType="pubmed">22993144</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaucourt S, Vignuzzi M. 2014. Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance. Curr Opin Virol 8:10–15. doi:10.1016/j.coviro.2014.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.04.011</ArticleId><ArticleId IdType="pmc">PMC7102760</ArticleId><ArticleId IdType="pubmed">24846716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnädig NF, Beaucourt S, Campagnola G, Bordería AV, Sanz-Ramos M, Gong P, Blanc H, Peersen OB, Vignuzzi M. 2012. Coxsackievirus B3 mutator strains are attenuated in vivo. Proc Natl Acad Sci 109:E2294–E2303. doi:10.1073/pnas.1204022109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1204022109</ArticleId><ArticleId IdType="pmc">PMC3427060</ArticleId><ArticleId IdType="pubmed">22853955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicmal TM, Tate PM, Dial CN, Esin JJ, Mounce BC. 2019. Polyamine depletion abrogates enterovirus cellular attachment. J Virol 93:e01054-19. doi:10.1128/JVI.01054-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01054-19</ArticleId><ArticleId IdType="pmc">PMC6798109</ArticleId><ArticleId IdType="pubmed">31341056</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighat A, Svitkin Y, Novoa I, Kuechler E, Skern T, Sonenberg N. 1996. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J Virol 70:8444–8450. doi:10.1128/JVI.70.12.8444-8450.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.70.12.8444-8450.1996</ArticleId><ArticleId IdType="pmc">PMC190934</ArticleId><ArticleId IdType="pubmed">8970966</ArticleId></ArticleIdList></Reference><Reference><Citation>Borman AM, Kirchweger R, Ziegler E, Rhoads RE, Skern T, Kean KM. 1997. elF4G and its proteolytic cleavage products: effect on initiation of protein synthesis from capped, uncapped, and IRES-containing mRNAs. RNA 3:186–196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369472</ArticleId><ArticleId IdType="pubmed">9042945</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi K, Kashiwagi K. 2000. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 271:559–564. doi:10.1006/bbrc.2000.2601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.2601</ArticleId><ArticleId IdType="pubmed">10814501</ArticleId></ArticleIdList></Reference><Reference><Citation>Dial CN, Tate PM, Kicmal TM, Mounce BC. 2019. Coxsackievirus B3 responds to polyamine depletion via enhancement of 2A and 3C protease activity. Viruses 11:403. doi:10.3390/v11050403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050403</ArticleId><ArticleId IdType="pmc">PMC6563312</ArticleId><ArticleId IdType="pubmed">31052199</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo MR, Petite MJ, LoMascolo NJ, Shah PS, Mounce BC. 2021. Polyamines and eIF5A hypusination facilitate SREBP2 translation and cholesterol synthesis to enhance enterovirus attachment and infection. bioRxiv. doi:10.1101/2021.11.01.465941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.01.465941</ArticleId><ArticleId IdType="pmc">PMC10146511</ArticleId><ArticleId IdType="pubmed">37071661</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond JE, Herbst EJ. 1968. Analysis of polyamines by thin-layer chromatography. Anal Biochem 22:474–484. doi:10.1016/0003-2697(68)90288-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(68)90288-1</ArticleId><ArticleId IdType="pubmed">5672493</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675. doi:10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dever TE, Gutierrez E, Shin B-S. 2014. The hypusine-containing translation factor eIF5A. Crit Rev Biochem Mol Biol 49:413–425. doi:10.3109/10409238.2014.939608.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10409238.2014.939608</ArticleId><ArticleId IdType="pmc">PMC4183722</ArticleId><ArticleId IdType="pubmed">25029904</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Poirier EZ, Passoni G, Simon-Loriere E, Cesaro T, Prot M, Stapleford KA, Moratorio G, Sakuntabhai A, Levraud J-P, Vignuzzi M. 2016. Interferon-induced spermidine-spermine acetyltransferase and polyamine depletion restrict Zika and chikungunya viruses. Cell Host Microbe 20:167–177. doi:10.1016/j.chom.2016.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.06.011</ArticleId><ArticleId IdType="pubmed">27427208</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel M-P, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M. 2016. Inhibition of polyamine biosynthesis is a broad-spectrum strategy against RNA viruses. J Virol 90:9683–9692. doi:10.1128/JVI.01347-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-16</ArticleId><ArticleId IdType="pmc">PMC5068521</ArticleId><ArticleId IdType="pubmed">27535047</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsebosch BM, Mounce BC. 2021. Polyamine analog diethylnorspermidine restricts coxsackievirus B3 and is overcome by 2A protease mutation in vitro. Viruses 13:310. doi:10.3390/v13020310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020310</ArticleId><ArticleId IdType="pmc">PMC7920041</ArticleId><ArticleId IdType="pubmed">33669273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A, Vu MN, Al-Hakeem A, Tran GP, Nguyen JHC, Semler BL. 2023. Enterovirus-cardiomyocyte interactions: impact of terminally deleted genomic RNAs on viral and host functions. J Virol 97:e0142622. doi:10.1128/jvi.01426-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01426-22</ArticleId><ArticleId IdType="pmc">PMC9888282</ArticleId><ArticleId IdType="pubmed">36475766</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A, Gretteau P-A, Wehbe M, Renois F, N'Guyen Y, Lévêque N, Vu MN, Tracy S, Chapman NM, Bruneval P, Fornes P, Semler BL, Andreoletti L. 2019. Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5’ terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities. Circulation 139:2326–2338. doi:10.1161/CIRCULATIONAHA.118.035966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035966</ArticleId><ArticleId IdType="pmc">PMC6517084</ArticleId><ArticleId IdType="pubmed">30755025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy S, Drescher KM. 2007. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann N Y Acad Sci 1103:143–151. doi:10.1196/annals.1394.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1394.009</ArticleId><ArticleId IdType="pubmed">17376828</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Calvo T. 2019. Enterovirus infection and type 1 diabetes: unraveling the crime scene. Clin Exp Immunol 195:15–24. doi:10.1111/cei.13223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13223</ArticleId><ArticleId IdType="pmc">PMC6300647</ArticleId><ArticleId IdType="pubmed">30307605</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781–785. doi:10.1038/nm0798-781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0798-781</ArticleId><ArticleId IdType="pubmed">9662368</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Calvo T. 2018. Enteroviral infections as a trigger for type 1 diabetes. Curr Diab Rep 18:106. doi:10.1007/s11892-018-1077-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-018-1077-2</ArticleId><ArticleId IdType="pubmed">30232567</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo MR, Mastrodomenico V, Hawkins GM, Prot M, Levillayer L, Gallagher T, Simon-Loriere E, Mounce BC. 2021. Targeting polyamines inhibits coronavirus infection by reducing cellular attachment and entry. ACS Infect Dis 7:1423–1432. doi:10.1021/acsinfecdis.0c00491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00491</ArticleId><ArticleId IdType="pmc">PMC7539557</ArticleId><ArticleId IdType="pubmed">32966040</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>